{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:51:10Z","timestamp":1793022670151,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cct.2026.108500","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:15:20Z","timestamp":1792595720000},"page":"108500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiopulmonary exercise testing-based high-intensity interval training delivered via synchronous telehealth for metabolic dysfunction-associated steatotic liver disease: protocol of the CPHIT-1 study"],"prefix":"10.1016","volume":"171","author":[{"given":"Chao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cct.2026.108500_bb0005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cct.2026.108500_bb0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the lLiver (EASL)","year":"2024","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cct.2026.108500_bb0015","article-title":"Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (version 2024)","volume":"32","author":"Chinese Society of Hepatology, Chinese Medical Association","year":"2024","journal-title":"Chin. J. Hepatol."},{"issue":"12","key":"10.1016\/j.cct.2026.108500_bb0020","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s40279-023-01918-w","article-title":"Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in adults: a position statement from exercise and sport science Australia","volume":"53","author":"Keating","year":"2023","journal-title":"Sports Med."},{"issue":"1","key":"10.1016\/j.cct.2026.108500_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000634","article-title":"Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study","volume":"8","author":"Tincopa","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"issue":"2","key":"10.1016\/j.cct.2026.108500_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pcad.2019.01.004","article-title":"Guidelines for the delivery and monitoring of high intensity interval training in clinical populations","volume":"62","author":"Taylor","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.cct.2026.108500_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197124","article-title":"Affective and enjoyment responses in high intensity interval training and continuous training: a systematic review and meta-analysis","volume":"13","author":"Oliveira","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cct.2026.108500_bb0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1113\/JP281210","article-title":"Low-volume high-intensity interval training for cardiometabolic health","volume":"600","author":"Sabag","year":"2022","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.cct.2026.108500_bb0045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/clinem\/dgab795","article-title":"The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis","volume":"107","author":"Sabag","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cct.2026.108500_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156677","article-title":"High-intensity interval training and moderate-intensity continuous training are effective, feasible, and safe for patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"182","author":"Wang","year":"2026","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.cct.2026.108500_bb0055","article-title":"Dietary guidelines for adults with hyperlipidemia (2023 version)","volume":"21","author":"National Health Commission of the People's Republic of China","year":"2023","journal-title":"Clin. Educ. Gen. Pract."},{"issue":"1","key":"10.1016\/j.cct.2026.108500_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2466\/pms.1998.86.1.183","article-title":"Perception of physical exertion during dynamic exercise: a tribute to professor Gunnar a. V. Borg","volume":"86","author":"Robertson","year":"1998","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.cct.2026.108500_bb0065","unstructured":"ICH harmonised tripartite Guideline, Guideline for Good Clinical Practice E6(R1), 1996. http:\/\/www. ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/ good-clinical-practice. html."},{"issue":"4","key":"10.1016\/j.cct.2026.108500_bb0070","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000323","article-title":"Diagnostic performance of FibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"12","author":"Qu","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"10","key":"10.1016\/j.cct.2026.108500_bb0075","article-title":"Chinese expert consensus on standardized clinical application of cardiopulmonary exercise testing","volume":"50","author":"Chinese Society of Cardiology, Chinese Medical Association","year":"2022","journal-title":"Chin. J. Cardiol."},{"issue":"4","key":"10.1016\/j.cct.2026.108500_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cct.2026.108500_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A phase 2 randomized trial of Survodutide in MASH and fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2026.108500_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083735","article-title":"Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial","volume":"389","author":"Lin","year":"2025","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cct.2026.108500_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12955-023-02195-x","article-title":"Cross-walk of the chronic liver disease questionnaire for nonalcoholic steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH","volume":"21","author":"Fishman","year":"2023","journal-title":"Health Qual. Life Outcomes"},{"issue":"7","key":"10.1016\/j.cct.2026.108500_bb0100","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1148\/rg.2019190034","article-title":"Liver MR elastography technique and image interpretation: pearls and pitfalls","volume":"39","author":"Guglielmo","year":"2019","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.cct.2026.108500_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1249\/MSS.0b013e318279a10a","article-title":"Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine","volume":"45","author":"Meeusen","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"issue":"10","key":"10.1016\/j.cct.2026.108500_bb0110","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2337\/dc19-2523","article-title":"The effect of a novel low-volume aerobic exercise intervention on liver fat in type 2 diabetes: a randomized controlled trial","volume":"43","author":"Sabag","year":"2020","journal-title":"Diabetes Care"},{"issue":"2 Suppl","key":"10.1016\/j.cct.2026.108500_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2047487314552764","article-title":"Optimising exercise training in prevention and treatment of diastolic heart failure (OptimEx-CLIN): rationale and design of a prospective, randomised, controlled trial","volume":"21","author":"Suchy","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cct.2026.108500_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1553846","article-title":"Customizing intense interval exercise training prescription using the \"frequency, intensity, time, and type of exercise\" (FITT) principle","volume":"16","author":"Stavrinou","year":"2025","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.cct.2026.108500_bb0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40279-023-01815-2","article-title":"Effects of high-intensity interval training protocols on blood lactate levels and cognition in healthy adults: systematic review and meta-regression","volume":"53","author":"Jacob","year":"2023","journal-title":"Sports Med."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:20:24Z","timestamp":1793020824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426002867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":25,"alternative-id":["S1551714426002867"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108500","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiopulmonary exercise testing-based high-intensity interval training delivered via synchronous telehealth for metabolic dysfunction-associated steatotic liver disease: protocol of the CPHIT-1 study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108500"}}